Medable vs Anthropic
Side-by-side comparison of AI visibility scores, market position, and capabilities
Medable raised $304M to build the leading decentralized clinical trial (DCT) platform, enabling remote patient participation, eConsent, and wearable data integration for pharmaceutical trials.
About
Medable provides the technology infrastructure for decentralized clinical trials (DCTs) — enabling pharmaceutical companies to conduct trials where patients participate from home rather than traveling to research sites. The platform covers the full DCT workflow: electronic informed consent (eConsent), remote patient monitoring via wearables, telemedicine visits, electronic clinical outcome assessments (eCOA), and direct-to-patient drug delivery coordination.
Claude 4 family (claude-opus-4-6, claude-sonnet-4-6, claude-haiku-4-5) at $5B ARR (2025); $183B valuation (Series F, Sept 2025); $14.3B raised — Amazon $8B, Google $2B; Claude Code at $500M+ ARR; 300K+ business customers; Claude.ai 18M+ MAU; competing with OpenAI o3/GPT-4.5, Google Gemini 2.0, Meta Llama 4.
About
Anthropic is a San Francisco-based AI safety and research company that builds the Claude family of large language models. As of 2026, the current Claude 4 generation includes claude-opus-4-6 (most capable, reasoning and agentic tasks), claude-sonnet-4-6 (balanced performance and speed), and claude-haiku-4-5 (fast and cost-efficient). Anthropic also offers Claude Code — an agentic CLI for software engineering — generating $500M+ ARR by mid-2025.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.